Vertex Q4 Earnings On Deck: Will This Biotech Heavyweight Keep Its Edge?
Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...
Vigil Neuroscience Inc (VIGL) Receives a Buy from Stifel Nicolaus
In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Vigil Neuroscience Inc (VIGL – Research Report), with ...
Lexeo Therapeutics, Inc. (LXEO) Gets a Buy from Stifel Nicolaus
In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Lexeo Therapeutics, Inc. (LXEO – Research Report), ...